SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

S5 - General Neurology: Pathogenesis, Modulation, and Biomarkers of Complex Neurological Disorders

Event Time: Sunday April 23, 2017 1:00 pm to 3:00 pm
Topic(s): General Neurology
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Program Speakers - Tentative

Start/End Time Title Faculty
2:35 PM - 3:00 PM Discussion Na Tosha Gatson MD, PhD 


Speaker Disclosure
Na Tosha N. Gatson, MD, PhD Dr. Gatson has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novocure (Optune).

Abstract Presenters

Start Time Pub. Title Presenter
1:00 PM 001 Impact of NEOD001 on Neuropathy in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction: Results From the Expansion Phase of a Phase 1/2 Study Michaela Liedtke
Dr. Liedtke has received personal compensation for activities with Prothena, Amgen, Takeda, and Pfizer as a consultant or advisor. Dr. Liedtke has received research support from Prothena, Amgen, Takeda, Pfizer, Celgene, and Novartis.

1:12 PM 002 Corticokinematic coherence is decreased in patients with Friedreich Ataxia and correlates with GAA1 expansion Gilles Naeije
Dr. Naeije has nothing to disclose.

1:24 PM 003 Long-Term Risk of Seizures in Survivors of Sepsis Michael Reznik, MD
Dr. Reznik has nothing to disclose.

1:36 PM 004 Impact of Neurological Magnetic Resonance Imaging in Non-Approved Cardiac Devices Lina Ya'qoub
Dr. Ya'qoub has nothing to disclose.

1:48 PM 005 Resting cerebral perfusion impairment in Type 2 Diabetes Weiying Dai
Dr. Dai has nothing to disclose.

2:00 PM 006 Clinical features of post-vaccination Guillain-Barrè Syndrome (GBS) in the Republic of Korea Bum Chun Suh
Dr. Suh has nothing to disclose.

2:12 PM 007 Specific human antisense oligonucleotide (ASO) targeting TGF-ßRII rescues proliferation of TGF-ß arrested human neuronal progenitor cells (ReNcell CX) Sabrina Kuespert, PhD
Dr. Kuespert has received personal compensation for activities with NeuroVision Pharma GmbH, Germany.

2:24 PM 008 Glia maturation factor inhibits mitochondrial biogenesis, increase oxidative stress and apoptotic cell death in dopaminergic neurons Govindhasamy Pushpavathi Selvakumar
Dr. Selvakumar has nothing to disclose.

Register Now

Related Courses

Saturday April 21, 2018

7:00 AM-9:00 AM
C2 Functional Neurologic Disorders I: Movement, Seizures, and Speech Disorders Alberto Espay MD, FAAN
7:00 AM-4:00 PM
C6 Neurology MOC Prep Course Nicholas Johnson MD
9:30 AM-11:30 AM
C8 Emergency Neurology: Evaluation of Coma, Meningitis, and Viral Encephalitis in the Emergency Room Jose Suarez MD
C12 Functional Neurologic Disorders II: Life Experiences and Management of Functional Disorders Alberto Espay MD, FAAN
12:00 PM-1:00 PM
Navigating the Annual Meeting App Carlayne Jackson MD, FAAN
1:30 PM-3:30 PM
C22 Critical Care Consultations for Neurohospitalists Vanja Douglas MD
4:15 PM-5:30 PM
PL1 Hot Topics Plenary Session

Wednesday April 25, 2018

7:00 AM-9:00 AM
C139 Neurologic Case Studies in Pregnancy Mary O'Neal MD
9:15 AM-11:30 AM
PL5 Frontiers in Neuroscience Plenary Session
1:00 PM-3:00 PM
C144 Neurology Update I: Epilepsy, Behavioral Neurology, and Neurologic Infections Ralph Jozefowicz MD, FAAN
C148 LGBTQI Health in Neurology Holly Hinson MD, MCR
3:30 PM-5:30 PM
C160 Neurology Update II: Movement Disorders, Spine Disorders, and Sleep Disorders Ralph Jozefowicz MD, FAAN
C168 CNS Toxicities Neeraj Kumar MD


Forgot Password?